Uveitic floaters - Causes, Treatment & When to See a Doctor

```html

What is Uveitic Floaters?

Floaters are tiny specks, threads, or cobweb‑like shadows that drift across a person’s field of vision. When these floaters occur as a result of inflammation inside the eye – specifically within the uveal tract (the iris, ciliary body, and choroid) – they are called uveitic floaters. The inflammation, known as uveitis, can cause protein‑rich fluid and cellular debris to leak into the vitreous (the clear gel that fills the back of the eye). As these particles float in the vitreous, they cast shadows on the retina, producing the visual phenomenon of floaters.

Uveitic floaters differ from “simple” age‑related floaters in that they often appear suddenly, may be accompanied by pain, redness, or light sensitivity, and signal an underlying inflammatory process that can threaten vision if left untreated.

Common Causes

Uveitis – the inflammatory condition that gives rise to uveitic floaters – can be triggered by many systemic or ocular disorders. The most frequent culprits include:

• Autoimmune diseases – e.g., ankylosing spondylitis, juvenile idiopathic arthritis, Behçet’s disease.
• Infectious agents – herpes simplex virus, varicella‑zoster virus, toxoplasmosis, syphilis, tuberculosis, Lyme disease.
• Systemic inflammatory diseases – sarcoidosis, inflammatory bowel disease, multiple sclerosis.
• Trauma – blunt or penetrating eye injury can incite intra‑ocular inflammation.
• Lens or retinal surgery – cataract extraction, vitrectomy, or retinal detachment repair may provoke postoperative uveitis.
• Masquerade syndromes – intra‑ocular lymphoma or leukemia that mimic inflammatory uveitis.
• HLA‑B27 associated uveitis – a genetic predisposition that often presents with acute anterior uveitis and prominent floaters.
• Idiopathic uveitis – in up to 30% of cases no clear cause is identified despite extensive work‑up.
• Drug‑induced inflammation – e.g., bisphosphonates, topical prostaglandin analogues.
• Systemic malignancies – paraneoplastic uveitis linked to melanoma or breast cancer.

Associated Symptoms

Floaters rarely appear in isolation when uveitis is present. Patients commonly report one or more of the following:

• Eye pain or discomfort – often described as a dull ache, worse with eye movement.
• Redness (conjunctival injection) – especially around the cornea.
• Photophobia – heightened sensitivity to light.
• Blurred or hazy vision – caused by inflammatory cells in the aqueous or vitreous.
• Decreased visual acuity – a drop in sharpness that may fluctuate.
• Flashing lights (photopsia) – often a sign of retinal involvement.
• Eye swelling or eyelid edema.
• Feeling of a “gritty” or “foreign body” sensation.

When to See a Doctor

While occasional floaters can be benign, the presence of uveitic floaters warrants prompt evaluation. Seek professional care if you notice any of the following:

• Sudden increase in the number or size of floaters.
• Accompanying eye pain, redness, or photophobia.
• Noticeable decline in visual clarity or ability to read signs.
• Flashes of light, especially if new or frequent.
• Partial loss of peripheral vision (a “shadow” or “curtain”).
• History of autoimmune disease, recent infection, or trauma.

Early evaluation helps prevent complications such as cataract, glaucoma, macular edema, or permanent vision loss.

Diagnosis

Ophthalmologists use a combination of patient history, physical examination, and specialized tests to confirm uveitic floaters and uncover the underlying cause.

1. Comprehensive Eye Exam

• Visual acuity testing.
• Slit‑lamp biomicroscopy – allows direct visualization of inflammation in the anterior segment (iris, ciliary body).
• Fundus examination (with dilated pupils) – assesses vitreous haze, retinal lesions, and optic nerve status.

2. Imaging & Ancillary Tests

• Optical Coherence Tomography (OCT) – provides cross‑sectional images of the retina to detect macular edema.
• Fluorescein Angiography (FA) – highlights retinal vasculitis or leakage.
• Ultrasound B‑scan – useful if media opacity (e.g., dense vitreous haze) limits view of the posterior segment.

3. Laboratory Work‑up

Based on clinical suspicion, labs may include:

• Complete blood count, ESR/CRP (inflammation markers).
• Serologic tests for infections: VDRL/RPR (syphilis), Quantiferon‑TB Gold, Lyme ELISA, toxoplasma IgG/IgM.
• Autoimmune panel: HLA‑B27 typing, ANA, RF, ACE (for sarcoidosis).
• Syphilis, HIV, and hepatitis panels when risk factors exist.

4. Systemic Evaluation

Collaboration with rheumatologists, infectious disease specialists, or internists may be necessary to manage systemic disease that could be driving the uveitis.

Treatment Options

Treatment aims to control inflammation, preserve vision, and address the underlying cause. Management is individualized and may involve both medical and lifestyle measures.

Medical Therapy

• Topical corticosteroids (e.g., prednisolone acetate 1%) – first‑line for anterior uveitis; reduce cellular infiltrates and floaters.
• Cycloplegic agents (e.g., atropine, cyclopentolate) – relieve pain from ciliary spasm and prevent posterior synechiae.
• Systemic corticosteroids – oral prednisone or IV methylprednisolone for intermediate/posterior uveitis or when topical therapy is insufficient.
• Immunomodulatory (steroid‑sparing) agents – methotrexate, mycophenolate mofetil, azathioprine, or biologics (adalimumab, infliximab) for chronic or recurrent disease.
• Antimicrobial therapy – targeted antibiotics/antivirals when an infectious pathogen is identified (e.g., trimethoprim‑sulfamethoxazole for toxoplasmosis, oral acyclovir for herpes).
• Intra‑ocular steroid implants – dexamethasone (Ozurdex) or fluocinolone (Iluvien) for persistent macular edema.

Procedural Interventions

• Pars plana vitrectomy – surgical removal of the vitreous gel can clear dense inflammatory debris, reduce floaters, and improve vision in selected cases.
• Laser photocoagulation – used to treat retinal vasculitis or neovascularization associated with uveitis.

Home & Supportive Care

• Adhere strictly to prescribed eye‑drop regimens; missing doses can precipitate flare‑ups.
• Protect eyes from bright sunlight with UV‑blocking sunglasses.
• Maintain good systemic control of associated illnesses (e.g., keep rheumatoid arthritis medication on schedule).
• Stay hydrated and avoid smoking – both support overall ocular health.
• Use a clean pillowcase and wash hands frequently to reduce the risk of secondary infection.

Prevention Tips

Because many causes of uveitic floaters are systemic, prevention focuses on reducing inflammatory triggers and early detection.

• Manage chronic autoimmune conditions with regular follow‑up and medication compliance.
• Promptly treat systemic infections (e.g., sexually transmitted infections, TB) to avoid ocular spread.
• Wear protective eyewear during high‑risk activities (sports, construction) to prevent trauma.
• Avoid unnecessary use of corticosteroid eye drops without medical supervision – they can mask early signs of infection.
• Schedule routine eye examinations annually, or more often if you have known risk factors.
• Maintain a balanced diet rich in omega‑3 fatty acids and antioxidants (leafy greens, fish) which may support ocular immune regulation.

Emergency Warning Signs

If any of the following occur, seek emergency ophthalmic care (e.g., emergency department or urgent‑care eye clinic) immediately:

• Sudden, severe eye pain unrelieved by medication.
• Rapid loss of vision or a “curtain” covering part of the visual field.
• New onset of flashing lights combined with an increase in floaters.
• Marked swelling of the eye or eyelids.
• High‑grade fever, chills, or systemic illness together with eye symptoms (possible infectious endophthalmitis).
• Persistent red eye that does not improve after 24‑48 hours of treatment.

Key Take‑aways

Uveitic floaters are a symptom of intra‑ocular inflammation that should never be ignored. Prompt evaluation, accurate diagnosis, and tailored treatment—often involving both topical and systemic therapy—are essential to preserve sight and address the underlying disease. Maintaining regular eye check‑ups, controlling systemic illnesses, and recognizing red‑flag symptoms empower patients to protect their vision.

References:

• Mayo Clinic. “Uveitis.” Accessed May 2024. https://www.mayoclinic.org
• American Academy of Ophthalmology. “Uveitis Clinical Guidelines.” 2023.
• Cleveland Clinic. “Floaters & Flashes.” Updated 2024.
• National Eye Institute (NEI). “Uveitis.” 2022.
• World Health Organization. “Toxoplasmosis – ocular disease.” 2023.

```